Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer.
about
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expressionClinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significanceFunctional assays for analysis of variants of uncertain significance in BRCA2.Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.
P2860
Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Strong evidence that the commo ...... ce in hereditary breast cancer
@nl
Strong evidence that the commo ...... e in hereditary breast cancer.
@ast
Strong evidence that the commo ...... e in hereditary breast cancer.
@en
type
label
Strong evidence that the commo ...... ce in hereditary breast cancer
@nl
Strong evidence that the commo ...... e in hereditary breast cancer.
@ast
Strong evidence that the commo ...... e in hereditary breast cancer.
@en
prefLabel
Strong evidence that the commo ...... ce in hereditary breast cancer
@nl
Strong evidence that the commo ...... e in hereditary breast cancer.
@ast
Strong evidence that the commo ...... e in hereditary breast cancer.
@en
P2093
P2860
P50
P356
P1476
Strong evidence that the commo ...... e in hereditary breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1186/BCR1291
P407
P577
2005-07-27T00:00:00Z
P5875
P6179
1002014026